Literature DB >> 11508263

Early cellular and molecular changes induced by diabetes in the retina.

M Lorenzi1, C Gerhardinger.   

Abstract

For several decades the pathobiology of diabetic retinopathy has been the object of conjecture and hypotheses. Indeed, very little was known about the cellular events triggered by diabetes in the retina and about the processes underlying the microangiopathy. In the last few years there has been a concerted effort to acquire such information, and the work has targeted not just the retinal vessels but more comprehensively the retina. The picture emerging is one of multiplicity: multiple cell types in the retina are affected early by diabetes and multiple processes are operative in the microangiopathy. The main abnormalities captured to date are altered expression of several genes, apoptosis, microthrombosis, and proinflammatory changes. The new information needs to be integrated into temporal and mechanistic sequences and further expanded but it is beginning to provide a framework for the cellular dimension of diabetic retinopathy.

Entities:  

Mesh:

Year:  2001        PMID: 11508263     DOI: 10.1007/s001250100544

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  62 in total

1.  Effects of protein kinase C inhibition and activation on proliferation and apoptosis of bovine retinal pericytes.

Authors:  F Pomero; A Allione; E Beltramo; S Buttiglieri; F D'Alù; E Ponte; A Lacaria; M Porta
Journal:  Diabetologia       Date:  2003-03-01       Impact factor: 10.122

Review 2.  Insulin like growth factor-1 and insulin-like growth factor binding proteins: their possible roles in both maintaining normal retinal vascular function and in promoting retinal pathology.

Authors:  Lynn C Shaw; Maria B Grant
Journal:  Rev Endocr Metab Disord       Date:  2004-08       Impact factor: 6.514

3.  -to: Gardiner TA, Anderson HR, Degenhardt T et al. (2003) prevention of retinal capillary basement membrane thickening in diabetic dogs by a non-steroidal anti-inflammatory drug. Diabetologia 46:1269-1275.

Authors:  S K Biswas; J B Lopes de Faria; J M Lopes de Faria
Journal:  Diabetologia       Date:  2004-04       Impact factor: 10.122

4.  Diabetic Retinopathy and the NMDA Receptor.

Authors:  Sylvia B. Smith
Journal:  Drug News Perspect       Date:  2002-05

Review 5.  Neurovascular cross talk in diabetic retinopathy: Pathophysiological roles and therapeutic implications.

Authors:  Elizabeth P Moran; Zhongxiao Wang; Jing Chen; Przemyslaw Sapieha; Lois E H Smith; Jian-Xing Ma
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-07-29       Impact factor: 4.733

6.  Differential expression of connective tissue growth factor in microglia and pericytes in the human diabetic retina.

Authors:  E J Kuiper; A N Witmer; I Klaassen; N Oliver; R Goldschmeding; R O Schlingemann
Journal:  Br J Ophthalmol       Date:  2004-08       Impact factor: 4.638

7.  Functional changes in the neural retina occur in the absence of mitochondrial dysfunction in a rodent model of diabetic retinopathy.

Authors:  Dustin R Masser; Laura Otalora; Nicholas W Clark; Michael T Kinter; Michael H Elliott; Willard M Freeman
Journal:  J Neurochem       Date:  2017-10-20       Impact factor: 5.372

8.  Human genetics of diabetic retinopathy: current perspectives.

Authors:  Daniel P K Ng
Journal:  J Ophthalmol       Date:  2010-07-13       Impact factor: 1.909

9.  Activation of PKC-delta and SHP-1 by hyperglycemia causes vascular cell apoptosis and diabetic retinopathy.

Authors:  Pedro Geraldes; Junko Hiraoka-Yamamoto; Motonobu Matsumoto; Allen Clermont; Michael Leitges; Andre Marette; Lloyd P Aiello; Timothy S Kern; George L King
Journal:  Nat Med       Date:  2009-11-01       Impact factor: 53.440

10.  FOXO1 plays an important role in enhanced microvascular cell apoptosis and microvascular cell loss in type 1 and type 2 diabetic rats.

Authors:  Yugal Behl; Padmaja Krothapalli; Tesfahun Desta; Sayon Roy; Dana T Graves
Journal:  Diabetes       Date:  2009-01-23       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.